Q-omics provides the consensus-scored RNU6ATAC5P profile across patient tissues and cancer cell-line models. RNU6ATAC5P expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, RNU6ATAC5P RNA expression shows 7,515 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight KIRC, and COAD as cancer lineages where RNU6ATAC5P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.